GoodRx Corp (GDRX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti

GoodRx Corp (GDRX) korporativ emblemasi va logotipi

GoodRx Holdings, Inc. (GDRX) rahbariyati hozirda o'sishni tezlashtirish uchun sog'liqni saqlash gigantlari bilan hamkorlikni yangilamoqda. Kompaniyaning joriy P/E ko'rsatkichi aktivlarni konsolidatsiya qilish bosqichini aks ettiradi va qiymat 22.40 darajasida saqlanmoqda. Istiqbollar millionlab foydalanuvchilarning ilova orqali chegirmalar izlash odati hamda bemorlar trafigini raqamli yo'naltirish orqali logistika xarajatlarini bartaraf etuvchi yuqori marjali agregator modeliga tayanadi.

GDRX GoodRx Corp: Narxning foydaga nisbati 04.07.2022 - 17.11.2026 oraligʻida

GoodRx Holdings, Inc. kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning umumiy tahlili:GoodRx Corp GDRX
GoodRx Gold tovar namunasi

P/E koeffitsiyenti biznesning bozor qiymatini uning sof foydasiga nisbatan belgilaydi, bu esa investorga investitsiyalarning qoplanish muddatini baholash va qiymat tuzoqlaridan qochish imkonini beradi. GoodRx Holdings, Inc. (GDRX) kompaniyasining prognoz qilinayotgan P/E koeffitsiyenti tahlili shuni ko'rsatadiki, raqamli platformaning atrof-muhitga ta'sir va infratuzilma bo'yicha past operatsion xarajatlari daromadlilikni bevosita oshiradi, natijada aksiyaning yakuniy investitsiya jozibadorligini belgilaydi.

Raqobatdosh kompaniyalar

Narx-foyda multiplikatori VEEV (Veeva Systems Inc)|P/E multiplikatori DOCS|HQY - Kapitalizatsiyaning foydaga nisbati|Waystar Health - Narx-foyda koeffitsiyenti|corvel.com (CRVL) - Kapitalizatsiyaning foydaga nisbati|Privia Health Group, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati HURN (Huron Consulting Group Inc.)|CERT (Certara) - Narx-foyda koeffitsiyenti|OMCL - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Schrodinger Inc|Phreesia, Inc. (PHR) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti OMDA (Omada Health)|Bozor narxining sof foydaga nisbati EVH|Narxning foydaga nisbati HealthStream Learning HSTM|Definitive Healthcare Inc. - Narxning foydaga nisbati|CCSI: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Agilon Health|ABSI: P/E multiplikatori|Narx-foyda multiplikatori SY|NRC (nrchealth.com) - P/E multiplikatori|USA Mobility (SPOK) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti OPRX (OptimizeRx Corporation)|Biznesning o‘zini qoplash muddati trubridge.com|Narxning foydaga nisbati Simulations Plus, Inc. SLP|Bozor narxining sof foydaga nisbati SOPH (SOPHiA GENETICS S.A.)|HCAT: Narx-foyda koeffitsiyenti|CareCloud Inc. (CCLD) - Narx-foyda koeffitsiyenti|RSSS (Research Solutions, Inc.) - Narx-foyda koeffitsiyenti|Narx-foyda koeffitsiyenti DLH Holdings Corp|Narxning foydaga nisbati OneMedNet Corp|Scienture Holdings (SCNX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Healthcare Triangle (HCTI)|Biznesning o‘zini qoplash muddati iSpecimen Inc|P/E multiplikatori BFRG (bullfrogai.com)|Biznesning o‘zini qoplash muddati SCWorx (WORX)|MSPR - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati icoreconnect.com ICCT|TRxADE Health Corp (MEDS) - Narxning foydaga nisbati|ORGS - Biznesning o‘zini qoplash muddati|RCM - Kompaniya qiymatining sof foydaga nisbati|SHCR (Sharecare) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Streamline Health (STRM)|P/E multiplikatori Syra Health (SYRA)|P/E multiplikatori AMEH (ApolloMed)|MODN: Narx-foyda multiplikatori|nextgen.com - P/E multiplikatori